Differential effects of oligomeric and fibrillar amyloid-β1–42 on astrocyte-mediated inflammation

Activated glia, as a result of chronic inflammation, are associated with amyloid-β peptide (Aβ) deposits in the brain of Alzheimer's disease (AD) patients. In vitro, glia are activated by Aβ inducing secretion of pro-inflammatory molecules. Recent studies have focused on soluble oligomers (or p...

Full description

Bibliographic Details
Main Authors: Jill A. White, Arlene M. Manelli, Kristina H. Holmberg, Linda J. Van Eldik, Mary Jo LaDu
Format: Article
Language:English
Published: Elsevier 2005-04-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996104003262
Description
Summary:Activated glia, as a result of chronic inflammation, are associated with amyloid-β peptide (Aβ) deposits in the brain of Alzheimer's disease (AD) patients. In vitro, glia are activated by Aβ inducing secretion of pro-inflammatory molecules. Recent studies have focused on soluble oligomers (or protofibrils) of Aβ as the toxic species in AD. In the present study, using rat astrocyte cultures, oligomeric Aβ induced initial high levels of IL-1β decreasing over time and, in contrast, fibrillar Aβ increased IL-1β levels over time. In addition, oligomeric Aβ, but not fibrillar Aβ, induced high levels of iNOS, NO, and TNF-α. Our results suggest that oligomers induced a profound, early inflammatory response, whereas fibrillar Aβ showed less increase of pro-inflammatory molecules, consistent with a more chronic form of inflammation.
ISSN:1095-953X